OXER1 role in BC progression was confirmed by esiRNA, a mixture of siRNA oligos for the silencing approach, as OXER1 knockdown induced a significant down-regulation of the PI3K/Akt/NF-κB pathway and a substantial decrease in RACK1 expression (Fig. 5A–E). Here, AKT1 is linked to breast cancer.